| Christopher S. Boerner |
Christopher S. Boerner is currently the Chairman & Chief Executive Officer at Bristol Myers Squibb Co. and also serves as a Director at Capital Health System, Inc. Previously, he held positions such as Marketing Director at Genentech, Inc., Independent Director at Achaogen, Inc., Vice President-Marketing at Dendreon Corp., and Executive Vice President-Commercial at Seagen Inc. He also worked as an Associate at McKinsey & Co., Inc. Dr. Boerner completed his undergraduate studies at Washington University in St. Louis and obtained graduate and doctorate degrees from the Haas School of Business. |
| Amanda Poole |
Amanda Poole has worked at Bristol Myers Squibb Co. since 2017. Her current position is Chief Human Resources Officer & Executive VP, which she has held since 2024. |
| Giovanni Caforio |
Dr. Giovanni Caforio, MD, is an Independent Director at Stryker Corp., an Executive Chairman at Bristol Myers Squibb Co., a Chairman & Chief Executive Officer at Bristol-Myers Squibb Romania SRL, a Member at The Business Roundtable and a Member at TJ Holdings LLC. He is on the Board of Directors at Stryker Corp., European Federation of Pharmaceutical Industries & Assns and Hun School of Princeton, Inc. Dr. Caforio was previously employed as a Co-Chairman by Pharmaceutical Research & Manufacturers of America, a General Manager by Abbott Laboratórios Lda., and a Member by CEO Roundtable on Cancer, Inc. He also served on the board at National Pharmaceutical Council and Capital Health System, Inc. He received his doctorate degree from Università degli Studi di Roma Tor Vergata. |
| Catalina Vargas |
Catalina Vargas is currently working as Chief of Staff at Bristol Myers Squibb Co. She has a graduate degree from Universidad de la Sabana and an undergraduate degree from Pontifical Xavierian University. |
| Samit Hirawat |
Samit Hirawat is currently the Chief Medical Officer & EVP-Drug Development at Bristol Myers Squibb Co. Prior to this, he was the Head- Global Oncology Development at Novartis AG from 2017 to 2019. He completed his undergraduate degree at SMS Medical College & Hospital. |
| Adam Lenkowsky |
Adam Lenkowsky currently works at Bristol Myers Squibb Co., as Chief Commercialization Officer & Executive VP from 2023. |
| Estelle Vester-Blokland |
Estelle Vester-Blokland is currently a Senior VP-Global Medical Affairs at Bristol Myers Squibb Co. She holds a doctorate degree from the University of Utrecht. |
| Greg Meyers |
Greg Meyers is currently the Chief Digital & Technology Officer at Bristol Myers Squibb Co. Prior to this, he was the Group Chief Information & Digital Officer at Syngenta Group Co., Ltd. from 2018 to 2022. Meyers received his undergraduate degree from Rutgers State University of New Jersey and his graduate degree from Temple University (Pennsylvania). |
| Cari Gallman |
Cari Gallman is currently working as the Executive Vice President-Corporate Affairs at Bristol Myers Squibb Co. She has an undergraduate degree from Princeton University and a graduate degree from Harvard Law School. |
| Kimberly McCutcheon Jablonski |
Kimberly McCutcheon Jablonski currently works at Turning Point Therapeutics, Inc., as Director from 2022, Mirati Therapeutics, Inc., as Secretary, Director & Vice President from 2024, Bristol-Myers Squibb FCT bêta, Inc., as Secretary & Director from 2021, Rayzebio, Inc., as Secretary, Director & Vice President from 2024, Karuna Therapeutics, Inc., as Secretary, Director & Vice President from 2024, Bristol Myers Squibb Co., as Secretary, Chief Compliance & Ethics Officer from 2023, and Cardioxyl Pharmaceuticals LLC, as President & Secretary. |
| Michelle Weese |
Michelle Weese is on the board of Krispy Kreme, Inc. and Executive Vice President-Corporate Affairs at Bristol Myers Squibb Co.
In her past career she occupied the position of Chief Executive Officer at Stratigence LLC and General Secretary-North America at Danone SA.
Ms. Weese received an undergraduate degree from Georgia State University. |
| Robert M. Plenge |
Robert M. Plenge is currently the Chief Research Officer, Head-Research & EVP at Bristol Myers Squibb Co. Prior to this, he was an Independent Director at Translate Bio, Inc. from 2019 to 2021. He was also the VP-Translational Development & Research at Celgene Corp. and Vice President & Head-Translational Medicine at Merck & Co., Inc. from 2013 to 2017. Before that, he was an Associate Member at The Brigham & Women's Hospital, Inc. and The Broad Institute, Inc. from 2007 to 2013. Plenge received his doctorate from Case Western Reserve University in 2000 and his undergraduate degree from the University of California San Diego in 1992. |
| Phil Holzer |
Phil Holzer is currently working as a Senior Vice President & Controller at Bristol Myers Squibb Co. He completed his undergraduate degree at The University of Tampa, Inc. |
| David V. Elkins |
David V. Elkins is currently an Independent Director at Tapestry, Inc. and the Chief Financial Officer & Executive Vice President at Bristol Myers Squibb Co. He also holds the position of CFO, Principal Accounting Officer & Executive VP at Celgene Corp. In the past, Mr. Elkins worked as the Director of Corporate Strategy & Development at Unisys Ltd. He served as the Chief Financial Officer & Executive Vice President at Becton, Dickinson & Co. from 2008 to 2012. He was also a Principal at The Boeing Co. and the CFO-Consumer Products, Medical Devices & Functions at Johnson & Johnson from 2014 to 2018. Prior to that, he was the Chief Financial Officer at AstraZeneca PLC from 2006 to 2008 and at AstraZeneca Pharmaceuticals LP from 1995 to 2008. He also held the position of Chief Financial Officer at Round Rock Research LLC from 2012 to 2014. Mr. Elkins completed his graduate degree at the University of Pennsylvania in 2003. He earned an MBA from Drexel University in 1995 and an undergraduate degree from the University of Delaware in 1991. |
| Louis S. Schmukler |
Louis S. Schmukler is currently the President-Global Product Development & Supply at Bristol Myers Squibb Co. He is also a Member of the National Association of Manufacturers, the Pharmaceutical Research & Manufacturers of America, the International Society for Pharmaceutical Engineering, and the Biophorum Operations Group Ltd. Previously, Mr. Schmukler held positions as the Senior VP-Pharmaceutical Operating Unit at Wyeth LLC, Principal at Sandoz, Inc., Vice President-Quality at Hoffmann-La Roche, Inc., and Principal at Marion Merrell Dow, Inc. Mr. Schmukler completed his undergraduate degree at Temple University (Pennsylvania) and his graduate degree at Webster University. |
| Deepak L. Bhatt |
Deepak L. Bhatt is an Independent Director at Bristol Myers Squibb Co. and a Director at High Enroll LLC. He is also a Professor at Harvard Medical School. Previously, he served as a Trustee at the American College of Cardiology Foundation. Bhatt received his undergraduate degree from Massachusetts Institute of Technology, his doctorate from Cornell University, and his graduate degree from Harvard T.H. Chan School of Public Health. |
| Phyllis R. Yale |
Phyllis R. Yale is an Independent Director at Bristol Myers Squibb Co., where she started in 2019. She is also an Independent Non-Executive Director at DaVita, Inc., starting in 2016. In addition, she serves as a Director at Aledade, Inc. since 2021 and at Blue Cross & Blue Shield of Massachusetts, Inc. from 2014 to the present. Ms. Yale is currently a Director at The Trustees of Reservations, The Bridgespan Group, Cradles To Crayons, and Montai Health, Inc. Formerly, Ms. Yale was the Chairman at Kindred Healthcare LLC from 2014 to 2018. She also held positions as a Director at NeighborCare, Inc. from 2003 to 2005, Pediatric Services of America LLC in 2007, National Surgical Hospitals LLC from 2011 to 2016, and Carelon Behavioral Health, Inc. from 2009 to 2014. Prior to that, she was a Partner at Bain & Co., Inc. from 1987 to 2010. Ms. Yale completed her undergraduate studies at Harvard University and holds an MBA from Harvard Business School. |
| Peter J. Arduini |
Peter J. Arduini currently works at GE Healthcare Technologies, Inc., as President, Chief Executive Officer & Director from 2022, Advanced Medical Technology Association, as Chairman from 2023, Bristol Myers Squibb Co., as Independent Director from 2016, Ascension Orthopedics, Inc., as President & Director, TEI Biosciences, Inc., as President & Director, Medical Device Innovation Consortium, as Director from 2016, Susquehanna University, as Trustee, and Ascención Orthopedics, Inc., as President. Mr. Arduini also formerly worked at Integra LifeSciences Holdings Corp., as President, Chief Executive Officer & Director from 2012 to 2021, GE Healthcare, Inc., as President & Chief Executive Officer from 2022 to 2023, National Italian American Foundation, Inc., as Director, Baxter Healthcare Corp., as President-Medical Delivery & Vice President from 2005 to 2010, Baxter International, Inc., as Vice President & President-Medication Delivery in 2010, General Electric Healthcare Technologies, Inc., as Global General Manager-CT Scan, and Medication Delivery Devices, Inc., as President & Vice President. Mr. Arduini received his undergraduate degree from Susquehanna University and graduate degree from Kellogg School of Management. |
| Paula A. Price |
Paula A. Price currently holds several director positions, including at Bristol Myers Squibb Co., Mutual of America Life Insurance Co., Accenture Plc, Blue Cross & Blue Shield of Massachusetts, Inc., Financial Guaranty Insurance Co., Accenture Ventures, and Warner Bros. Discovery, Inc. She has previously held director positions at Charming Shoppes, Inc., Dollar General Corp., Western Digital Corp., DaVita, Inc., Macy's, Inc., CVS Health Corp., JPMorgan Chase & Co., Ahold USA, Inc., Newton-Wellesley Hospital Corp., Stop & Shop Cos., Inc., Roebuck & Co., and Giant Landover. Additionally, she has served as a trustee for Newton-Wellesley Hospital Corp. and as a director of financial planning and analysis at Mondelez International, Inc. She received an undergraduate degree from DePaul University and an MBA from The University of Chicago Booth School of Business. |
| Derica W. Rice |
Derica W. Rice is an Independent Director at Bristol Myers Squibb Co., The Walt Disney Co., Target Corp., and Carlyle Investment Management LLC. He is also a Director at Carlyle Group Inc., Clarian Health North LLC, Center for Leadership Development, Inc., Tessera Therapeutics, Inc., and The Carlyle Group LP (Global Private Equity). In the past, he served as a Director at ImClone LLC, Target Corp., Indiana University Health, Inc., and Indianapolis Museum of Art, Inc. He was the Chief Financial Officer & EVP-Global Services at Eli Lilly & Co. from 2006 to 2017. He also held positions at CVS Health Corp., Eli Lilly Canada, Inc., Eli Lilly & Co. Ltd., and Caremark LLC. Mr. Rice holds an MBA from Indiana University and an undergraduate degree from Kettering University. |
| Manuel Hidalgo Medina |
Manuel Hidalgo Medina is currently an Independent Director at Bristol Myers Squibb Co., a Director-Special Conference Clinical Research at American Association for Cancer Research, and a Professor at Weill Cornell Medical College. Previously, he was a Professor at Harvard University from 2015 to 2019. He holds a doctorate degree from the University of Navarra and Universidad Autónoma de Madrid. |
| Theodore Rapp Samuels |
Theodore Rapp Samuels is currently an Independent Director at Bristol Myers Squibb Co., Centene Corp., and Iron Mountain, Inc. He also serves as a Director at Research Corporation Technologies, Inc., Capital Group Foundation, John Burroughs School, and Pasadena City College Foundation. In the past, he served as Co-Chairman at Children's Hospital Los Angeles, Independent Director at Auctane, Inc., Perrigo Co. Plc, and Portfolio Manager at Capital International, Inc. He was also President at Capital Guardian Trust Co. from 2010 to 2017. Mr. Samuels received his undergraduate degree from Harvard University in 1977 and his MBA from Harvard Business School in 1981. |
| Gerald L. Storch |
Gerald L. Storch is the founder of Storch Advisors, Inc. founded in 2013, where he held the position of Chairman & Chief Executive Officer until 2014. Currently, he is the Chief Executive Officer at Storch Advisors, Inc. since 2017. He is also an Independent Director at Bristol Myers Squibb Co. since 2012 and a Director at Fanatics LLC since 2013. Additionally, he is a Director at Toys "R" Us Children's Fund, Inc., Fanatics Holdings, Inc., a Member at Chief Executives For Corporate Purpose, Inc., and a Committee Member at International Council of Toy Industries. His former positions include Chairman & Chief Executive Officer at Toys "R" Us, Inc. from 2006 to 2013, Chairman & Chief Executive Officer at Toys R US SARL from 2006 to 2013, Vice Chairman at Target Corp. from 1993 to 2005, Non-Executive Chairman at SUPERVALU, Inc. from 2014 to 2017, and Chief Executive Officer & Director at Hudson's Bay Co. from 2015 to 2017. He was also a Partner at McKinsey & Co., Inc. from 1982 to 1993. Mr. Storch's education includes an MBA from Harvard Business School, a graduate degree from Harvard Law School, and an undergraduate degree from Harvard College. |
| Julia A. Haller |
Julia A. Haller is currently the Chairman of the Ophthalmology Department & Professor at Sidney Kimmel Medical College. She is also the Chairman at The College of Physicians of Philadelphia. Additionally, she serves as an Independent Director at Bristol Myers Squibb Co., an Independent Non-Executive Director at Opthea Ltd., a Director at Kimmel Center, Inc., a Director at The Philadelphia Orchestra Association, and a Director at the Association of University Professors of Ophthalmology. Dr. Haller is also an Independent Director at Outlook Therapeutics, Inc. and the President & Director of The Johns Hopkins Medical & Surgical Association. She is a Director at The Society of Heed Fellows and a Professor at Thomas Jefferson University Hospital. Furthermore, she holds the position of Treasurer at Macula Society. Previously, Dr. Haller served as the Ophthalmologist-in-Chief at Wills Eye Health System & Wills Eye Institute. She was also a Member of the National Academy of Medicine and a Member-Governors Board at ARVO Foundation for Eye Research. Dr. Haller is the former Independent Director at Celgene Corp. and the former Independent Director at Eyenovia, Inc. She was a Trustee at Princeton University and the Chief Resident at Wilmer Eye Institute. Dr. Haller has also worked as a Professor at The Johns Hopkins University School of Medicine. In terms of education, she completed her undergraduate degree at Princeton University and obtained her doctorate from Harvard Medical School. |
| Karen H. Vousden |
Karen H. Vousden is the founder of Faeth Therapeutics, Inc. She is currently an Independent Director at Bristol Myers Squibb Co., an Associate at National Academy of Sciences, a Council Member at European Molecular Biology Organization, and the President of British Association for Cancer Research. Previously, she was the Director of The Beatson Institute For Cancer Research from 2002 to 2016. |
